Papers
3
Total Citations
389
H-Index
2
About
John FitzGerald is a urologic surgeon and clinical researcher whose work has made meaningful contributions to the field of urologic oncology, with a particular focus on bladder cancer treatment and surgical innovation. He is best known for his pioneering role in conducting one of the first prospective randomized clinical trials comparing robotic-assisted laparoscopic radical cystectomy (RARC) to traditional open radical cystectomy (ORC) — a study that has garnered over 280 citations and addressed longstanding gaps left by retrospective, bias-prone research. This landmark 2012 trial provided rigorous evidence on perioperative outcomes and oncologic efficacy, helping establish a stronger evidence base for robotic surgical approaches in bladder cancer care. FitzGerald further extended this work in 2014 by examining health-related quality of life outcomes between the two surgical approaches in a prospective randomized setting, contributing over 100 additional citations to the literature. Together, these studies reflect his commitment to patient-centered, evidence-driven surgical research. His collaborative approach, demonstrated through multi-author clinical investigations, underscores his role as an important contributor to advancing minimally invasive urology and improving outcomes for patients facing one of the most complex urological malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3